Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | GBA1 | P04062 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | PPARG | P37231 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12617445 | 0.91 | DHODH (0.42) | MAPTKMT2AKDM4EALDH1A1MEN1 | |
| SCHEMBL294861 | 0.89 | PDE3B (0.46) | MAPTKMT2AKDM4EMEN1SMN1; SMN2 | |
| SCHEMBL4825877 | 0.89 | PDE3B (0.46) | MAPTKMT2AKDM4EMEN1SMN1; SMN2 | |
| SCHEMBL12618037 | 0.88 | PDK2 (0.41) | MAPTKMT2AKDM4EMEN1SMN1; SMN2 | |
| SCHEMBL24915296 | 0.87 | HDAC1 (0.42) | CNR1CNR2GPR55PTPN11 | |
| SCHEMBL20433717 | 0.87 | LMNA (0.40) | MAPTKMT2AKDM4EMEN1SMN1; SMN2 | |
| SCHEMBL15599733 | 0.87 | PDE3B (0.44) | MAPTKMT2AKDM4EMEN1SMN1; SMN2 | |
| SCHEMBL12617451 | 0.87 | CNR2 (0.49) | CNR2PTPN11 | |
| SCHEMBL12617540 | 0.87 | CNR2 (0.49) | CNR2PTPN11 | |
| SCHEMBL31158097 | 0.87 | CNR2 (0.49) | CNR2PTPN11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9969702-B2 | Triazine compound and synthetic resin composition using same | ADEKA CORPORATION (JP) | 2018-05-15 | — | — | US | disclosed |
| US-20170327475-A1 | NOVEL TRIAZINE COMPOUND AND SYNTHETIC RESIN COMPOSITION USING SAME | ADEKA CORPORATION (JP) | 2017-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170327475-A1 | NOVEL TRIAZINE COMPOUND AND SYNTHETIC RESIN COMPOSITION USING SAME | PSMB5, SEM1, MRPS35 | MAPT 1281/4885KMT2A 2277/4885KDM4E 2097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.